December 5th 2017 – EMA – Platform for post-authorization studies registered as EU trade mark (EUTM)


The European Union Intellectual Property Office (EUIPO) approved the registration of ‘EU PAS Register’ as a European Union trade mark (EUTM) in July 2017, marking the official launching.

The project aims to be accessible and transparent to all current and future Member States of the European Union. Moreover, the EU PAS (Post Authorization Studies) Register helps to facilitate peer-review of protocols and results, and ensures compliance with EU pharmacovigilance legislation requirements.

1,145 studies have already been registered, among which 50% were requested by European authorities. EUTM is internationally recognized as a post-authorization studies platform.

Furthermore, foreign researchers are encouraged to enrich the content of the platform by publishing their own studies.